Notice2023-12963
Notice of Award of a Single-Source Cooperative Agreement To Fund the National Institute for Communicable Diseases, Republic of South Africa
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 16, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $2,000,000, with an expected total funding of approximately $11,500,000 over a five-Year period, to the National Institute for Communicable Diseases, Republic of South Africa. The award will support research studies on influenza and other respiratory pathogens of public health import in South Africa.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 116 (Friday, June 16, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 116 (Friday, June 16, 2023)]
[Notices]
[Page 39432]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-12963]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
the National Institute for Communicable Diseases, Republic of South
Africa
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $2,000,000, with an expected total funding of
approximately $11,500,000 over a five-Year period, to the National
Institute for Communicable Diseases, Republic of South Africa. The
award will support research studies on influenza and other respiratory
pathogens of public health import in South Africa.
DATES: The period for this award will be September 1, 2024 through
August 31, 2029.
FOR FURTHER INFORMATION CONTACT: Dr. Amy Yang, National Center for HIV,
Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control
and Prevention, 1600 Clifton Road NE, Mailstop US8-1, Atlanta, Georgia
30329 Telephone: 404-718-8836. Email: <a href="/cdn-cgi/l/email-protection#64253d050a03240700074a030b12"><span class="__cf_email__" data-cfemail="014058606f66416265622f666e77">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The single-source award will conduct
research on surveillance (including epidemiology, disease burden,
transmission, and laboratory methods), preventive tools and strategies
(e.g., vaccines, antivirals), and strategies for increasing coverage of
morbidity and mortality mitigating interventions. Data will be used to
inform prioritization of public health interventions in high-risk
populations in South Africa, regionally and globally.
The National Institute for Communicable Diseases is in a unique
position to conduct this work, as it is the only sufficiently advanced
governmental research, public health institute, and laboratory in the
sub-region that can perform sophisticated studies and laboratory
analyses required to understand influenza disease burden, evaluate
intervention efficacy and effectiveness, and intervention scale-up that
is in the Southern Hemisphere.
Summary of the Award
Recipient: National Institute for Communicable Diseases, Republic
of South Africa
Purpose of the Award: The purpose of this award is to conduct
research studies on influenza and other respiratory pathogens of public
health import in South Africa, specifically, focusing on surveillance
(including epidemiology, disease burden, transmission, and laboratory
methods), preventive tools and strategies (e.g., vaccines, antivirals),
and strategies for increasing coverage of morbidity and mortality
mitigating interventions. Data will be used to inform prioritization of
public health interventions in high-risk populations in South Africa,
regionally and globally.
Amount of Award: $2,000,000 in Federal fiscal year (FFY) 2024
funds, with a total estimated $11,500,000 for the 5-year period of
performance, subject to availability of funds.
Authority: This program is authorized under Public Health Service
Act, section 307 [42 U.S.C. 242l], as amended.
Period of Performance: September 1, 2024 through August 31, 2029.
Dated: June 13, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023-12963 Filed 6-15-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 16, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.